# Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis

> **NCT02230696** · PHASE3 · COMPLETED · sponsor: **Padagis LLC** · enrollment: 951 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray
- **DRUG:** Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray
- **DRUG:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT02230696
- **Lead sponsor:** Padagis LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 951 (ACTUAL)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02230696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02230696, "Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02230696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*